
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:media="http://search.yahoo.com/mrss/"  version="2.0">

<channel>
	<title>Herbert Loong: When Dali Became the Global Capital of Sarcoma &#8211; Oncology News, Insights, Stories by OncoDaily</title>
	<link>https://oncodaily.com</link>
	<description>Oncology News, Cancer Research &#38; Clinical Insights</description>
	<lastBuildDate>Sun, 26 Jul 2026 20:35:24 +0000</lastBuildDate>
	<language>en-US</language>
	<ttl>10</ttl>
	<copyright><![CDATA[P53 Inc.]]></copyright>
	<generator>Oncodaily.com</generator>
	<image>
		<url>https://oncodaily.com/pub/themes/oncodailynews/img/logo-ODN-round.png</url>
		<title>OncoDaily News</title>
		<link>https://oncodaily.com</link>
	</image>

	
<image>
	<url>https://oncodaily.com/pub/uploads/2025/10/OD-favicon-blank-320x320.webp</url>
	<title>Herbert Loong: When Dali Became the Global Capital of Sarcoma &#8211; Oncology News, Insights, Stories by OncoDaily</title>
	<link>https://oncodaily.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Herbert Loong: When Dali Became the Global Capital of Sarcoma</title>
		<link>https://oncodaily.com/voices/herbert-loong-552071</link>
		<media:thumbnail url="https://oncodaily.com/pub/uploads/2026/07/1785053386117.webp" />
		<pubDate>Sun, 26 Jul 2026 20:35:24 +0000</pubDate>
		<guid isPermaLink="false">426722679c03a3183a8fcb2e6fb2c274</guid>
				<category><![CDATA[Voices]]></category>
		<category><![CDATA[Bone Sarcoma]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[cancer care]]></category>
		<category><![CDATA[Cancer research]]></category>
		<category><![CDATA[Connective Tissue Oncology Society]]></category>
		<category><![CDATA[CTOS]]></category>
		<category><![CDATA[global oncology]]></category>
		<category><![CDATA[Herbert Loong]]></category>
		<category><![CDATA[International collaboration]]></category>
		<category><![CDATA[Lu Xie]]></category>
		<category><![CDATA[Musculoskeletal Oncology]]></category>
		<category><![CDATA[Musculoskeletal Tumor Society]]></category>
		<category><![CDATA[OncoDaily]]></category>
		<category><![CDATA[Oncology]]></category>
		<category><![CDATA[Orthopedic Oncology]]></category>
		<category><![CDATA[sarcoma]]></category>
		<category><![CDATA[sarcoma care]]></category>
		<category><![CDATA[sarcoma oncology]]></category>
		<category><![CDATA[sarcoma research]]></category>
		<category><![CDATA[soft tissue sarcoma]]></category>
		<category><![CDATA[surgical oncology]]></category>
		<category><![CDATA[TARPSWG]]></category>
		<category><![CDATA[Xiaodong Tang]]></category>
					<description><![CDATA[<img src="https://oncodaily.com/pub/uploads/2026/07/1785053386117.webp"/> <br/> <br/> Herbert Loong, Advisor at Greater Bay Area International Clinical Trial Institute, and Steering Committee Member at Lung Cancer Policy Network, shared on LinkedIn: &#8220;What are the chances of getting the [&#8230;]]]></description>
							</item>
	</channel>
</rss>
